ImageneBio, Inc.
corporate_fare Company Profile
ImageneBio, Inc. (NASDAQ:IMA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for IMA at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- ImageneBio Secures Substantial Cash Runway of $135.3M, Reports Improved Full-Year EPS
- ImageneBio Cuts 2025 Loss Per Share by Over 50% to $9.64
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$800K
Net Income
-$45.35M
Diluted EPS
-$9.64
Op. Cash Flow
-$47.84M
Operating Income
-$48.45M
Cash & Equivalents
$94.53M
Total Debt
$0
Debt / Equity
0.00×
Net Margin
-56.69×
Shares Outstanding
4.87M sh
Source: 10-K · filed 2026-03-10 · accession 0001193125-26-099434
show_chartPrice Chart
Loading chart...